nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—MUC2—gonad—adrenal gland cancer	0.0102	0.197	CbGeAlD
Pranlukast—CYP2C9—urine—adrenal gland cancer	0.0069	0.134	CbGeAlD
Pranlukast—Candesartan—ABCB1—adrenal gland cancer	0.00619	1	CrCbGaD
Pranlukast—NFKB1—gonad—adrenal gland cancer	0.00579	0.112	CbGeAlD
Pranlukast—NFKB1—cardiac atrium—adrenal gland cancer	0.00578	0.112	CbGeAlD
Pranlukast—NFKB1—pituitary gland—adrenal gland cancer	0.00565	0.11	CbGeAlD
Pranlukast—CYP3A4—urine—adrenal gland cancer	0.00526	0.102	CbGeAlD
Pranlukast—NFKB1—adrenal gland—adrenal gland cancer	0.00504	0.098	CbGeAlD
Pranlukast—CYSLTR1—adrenal gland—adrenal gland cancer	0.00496	0.0962	CbGeAlD
Pranlukast—NFKB1—Adaptive Immune System—SH3KBP1—adrenal gland cancer	0.00248	0.00263	CbGpPWpGaD
Pranlukast—TNF—Downstream signaling in naïve CD8+ T cells—BRAF—adrenal gland cancer	0.00247	0.00263	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—GNAS—adrenal gland cancer	0.00247	0.00262	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—CDC42—adrenal gland cancer	0.00247	0.00262	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—CDC42—adrenal gland cancer	0.00245	0.0026	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—CDC42—adrenal gland cancer	0.00242	0.00257	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00239	0.00254	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—BAD—adrenal gland cancer	0.00239	0.00253	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Receptor Signaling Pathway—BRAF—adrenal gland cancer	0.00239	0.00253	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—IGF2—adrenal gland cancer	0.00238	0.00252	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—GNAS—adrenal gland cancer	0.00236	0.0025	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—BAD—adrenal gland cancer	0.00235	0.0025	CbGpPWpGaD
Pranlukast—NFKB1—Cytosolic sensors of pathogen-associated DNA—CTNNB1—adrenal gland cancer	0.00235	0.00249	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—POMC—adrenal gland cancer	0.00234	0.00248	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—TSHR—adrenal gland cancer	0.00232	0.00247	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—adrenal gland cancer	0.00232	0.00246	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—CDKN2A—adrenal gland cancer	0.00231	0.00245	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00231	0.00245	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00225	0.00239	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—BAD—adrenal gland cancer	0.00224	0.00238	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.00223	0.00236	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—PRKACA—adrenal gland cancer	0.00217	0.00231	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—CDKN2A—adrenal gland cancer	0.00217	0.0023	CbGpPWpGaD
Pranlukast—TNF—TGF-beta Receptor Signaling—CTNNB1—adrenal gland cancer	0.0021	0.00223	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—NR5A1—adrenal gland cancer	0.00209	0.00222	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.00208	0.00221	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—BAD—adrenal gland cancer	0.00208	0.00221	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00206	0.00219	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.00205	0.00217	CbGpPWpGaD
Pranlukast—ABCC2—adrenal gland—adrenal gland cancer	0.00198	0.0385	CbGeAlD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—adrenal gland cancer	0.00193	0.00205	CbGpPWpGaD
Pranlukast—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—CDKN2A—adrenal gland cancer	0.00193	0.00205	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—BAD—adrenal gland cancer	0.00191	0.00203	CbGpPWpGaD
Pranlukast—NFKB1—LPA receptor mediated events—EGFR—adrenal gland cancer	0.00191	0.00202	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—PRKACA—adrenal gland cancer	0.0019	0.00201	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00189	0.00201	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.00189	0.00201	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.00189	0.00201	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—CDKN2A—adrenal gland cancer	0.00188	0.00199	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00187	0.00199	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—PRKACA—adrenal gland cancer	0.00186	0.00198	CbGpPWpGaD
Pranlukast—NFKB1—AGE/RAGE pathway—EGFR—adrenal gland cancer	0.00186	0.00197	CbGpPWpGaD
Pranlukast—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—adrenal gland cancer	0.00185	0.00196	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00185	0.00196	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—CDC42—adrenal gland cancer	0.00184	0.00196	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—BAD—adrenal gland cancer	0.00184	0.00195	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—EGFR—adrenal gland cancer	0.00184	0.00195	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00184	0.00195	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of Telomerase—EGFR—adrenal gland cancer	0.00182	0.00193	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—CTNNB1—adrenal gland cancer	0.0018	0.00191	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—CDKN2A—adrenal gland cancer	0.00176	0.00187	CbGpPWpGaD
Pranlukast—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00176	0.00187	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00172	0.00182	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—BAD—adrenal gland cancer	0.0017	0.0018	CbGpPWpGaD
Pranlukast—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00168	0.00178	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	0.00167	0.00178	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00167	0.00177	CbGpPWpGaD
Pranlukast—NFKB1—Neural Crest Differentiation—CTNNB1—adrenal gland cancer	0.00167	0.00177	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00167	0.00177	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00167	0.00177	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—CTNNB1—adrenal gland cancer	0.00167	0.00177	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MED12—adrenal gland cancer	0.00165	0.00175	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	0.00165	0.00175	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—BAD—adrenal gland cancer	0.00162	0.00172	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00161	0.00171	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.00159	0.00168	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—TP53—adrenal gland cancer	0.00158	0.00168	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—CTNNB1—adrenal gland cancer	0.00157	0.00167	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—TP53—adrenal gland cancer	0.00156	0.00166	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.00156	0.00166	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00156	0.00165	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—TP53—adrenal gland cancer	0.00154	0.00164	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—GNRH1—adrenal gland cancer	0.00154	0.00163	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—BRAF—adrenal gland cancer	0.00154	0.00163	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—RB1—adrenal gland cancer	0.00153	0.00162	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.00152	0.00162	CbGpPWpGaD
Pranlukast—IL5—Immune System—PRKACA—adrenal gland cancer	0.00152	0.00162	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—SH3KBP1—adrenal gland cancer	0.0015	0.00159	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—BAD—adrenal gland cancer	0.0015	0.00159	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00149	0.00158	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—adrenal gland cancer	0.00147	0.00156	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CDC42—adrenal gland cancer	0.00141	0.0015	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—RB1—adrenal gland cancer	0.00141	0.0015	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SPRY2—adrenal gland cancer	0.00141	0.0015	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—RB1—adrenal gland cancer	0.00139	0.00148	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TSHR—adrenal gland cancer	0.00137	0.00146	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—BAD—adrenal gland cancer	0.00137	0.00146	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—GNAS—adrenal gland cancer	0.00135	0.00143	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—TP53—adrenal gland cancer	0.00131	0.00139	CbGpPWpGaD
Pranlukast—IL5—Immune System—CDC42—adrenal gland cancer	0.00129	0.00137	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MEN1—adrenal gland cancer	0.00129	0.00137	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TP53—adrenal gland cancer	0.00129	0.00137	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00128	0.00135	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—POMC—adrenal gland cancer	0.00127	0.00135	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MED12—adrenal gland cancer	0.00126	0.00133	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.00126	0.00133	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—PTGS2—adrenal gland cancer	0.00126	0.00133	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—CDKN2A—adrenal gland cancer	0.00122	0.0013	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	0.00121	0.00128	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—TP53—adrenal gland cancer	0.00121	0.00128	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.0012	0.00127	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—TP53—adrenal gland cancer	0.00119	0.00126	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00118	0.00125	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—BRAF—adrenal gland cancer	0.00117	0.00124	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.00116	0.00123	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.00112	0.00119	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00112	0.00119	CbGpPWpGaD
Pranlukast—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00111	0.00118	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00111	0.00117	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—BAD—adrenal gland cancer	0.0011	0.00117	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00107	0.00113	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—PRKACA—adrenal gland cancer	0.00106	0.00113	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—RB1—adrenal gland cancer	0.00105	0.00112	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—TP53—adrenal gland cancer	0.00104	0.00111	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00104	0.00111	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—CTNNB1—adrenal gland cancer	0.00104	0.0011	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—TP53—adrenal gland cancer	0.00103	0.00109	CbGpPWpGaD
Pranlukast—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00102	0.00108	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—CDC42—adrenal gland cancer	0.00102	0.00108	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—PRKACA—adrenal gland cancer	0.00102	0.00108	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00102	0.00108	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00101	0.00107	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—BRAF—adrenal gland cancer	0.001	0.00107	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.001	0.00106	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—POMC—adrenal gland cancer	0.001	0.00106	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PRKACA—adrenal gland cancer	0.000985	0.00105	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TSHR—adrenal gland cancer	0.000985	0.00105	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—adrenal gland cancer	0.000981	0.00104	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000971	0.00103	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00097	0.00103	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	0.000959	0.00102	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MEN1—adrenal gland cancer	0.000926	0.000983	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CDKN2A—adrenal gland cancer	0.000925	0.000982	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000913	0.000969	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—POMC—adrenal gland cancer	0.00091	0.000966	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—CTNNB1—adrenal gland cancer	0.000903	0.000958	CbGpPWpGaD
Pranlukast—IL5—Immune System—BAD—adrenal gland cancer	0.000902	0.000957	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CDC42—adrenal gland cancer	0.000902	0.000957	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000898	0.000953	CbGpPWpGaD
Pranlukast—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000898	0.000953	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—EGFR—adrenal gland cancer	0.00089	0.000944	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—adrenal gland cancer	0.000885	0.000939	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—EGFR—adrenal gland cancer	0.00088	0.000934	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CDC42—adrenal gland cancer	0.000866	0.000919	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000854	0.000906	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—EGFR—adrenal gland cancer	0.000844	0.000896	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CDC42—adrenal gland cancer	0.000836	0.000887	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IGF2—adrenal gland cancer	0.000806	0.000855	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	0.000805	0.000854	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—GNAS—adrenal gland cancer	0.000799	0.000848	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000795	0.000843	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—EGFR—adrenal gland cancer	0.000781	0.000829	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IGF1R—adrenal gland cancer	0.000779	0.000827	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CDC42—adrenal gland cancer	0.000778	0.000826	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000764	0.000811	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TP53—adrenal gland cancer	0.000753	0.000799	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TP53—adrenal gland cancer	0.000747	0.000793	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TP53—adrenal gland cancer	0.000739	0.000784	CbGpPWpGaD
Pranlukast—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00073	0.000775	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000726	0.000771	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000719	0.000763	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000707	0.00075	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—TP53—adrenal gland cancer	0.000681	0.000723	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—EGFR—adrenal gland cancer	0.000671	0.000712	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TERT—adrenal gland cancer	0.000671	0.000712	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000667	0.000708	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—POMC—adrenal gland cancer	0.000653	0.000693	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—BAD—adrenal gland cancer	0.000629	0.000668	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000626	0.000664	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PRKACA—adrenal gland cancer	0.000619	0.000657	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000605	0.000642	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—BAD—adrenal gland cancer	0.000604	0.000641	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—adrenal gland cancer	0.000601	0.000637	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CDC42—adrenal gland cancer	0.0006	0.000637	CbGpPWpGaD
Pranlukast—IL5—Immune System—CTNNB1—adrenal gland cancer	0.000594	0.00063	CbGpPWpGaD
Pranlukast—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000592	0.000628	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000589	0.000625	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—BAD—adrenal gland cancer	0.000583	0.000619	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IGF2—adrenal gland cancer	0.000578	0.000614	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000578	0.000613	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—EGFR—adrenal gland cancer	0.000575	0.00061	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GNAS—adrenal gland cancer	0.000573	0.000608	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000573	0.000608	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TP53—adrenal gland cancer	0.000563	0.000598	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000559	0.000593	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TSHR—adrenal gland cancer	0.000558	0.000592	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—POMC—adrenal gland cancer	0.000538	0.000571	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—BRAF—adrenal gland cancer	0.000531	0.000564	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CDC42—adrenal gland cancer	0.000525	0.000557	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MEN1—adrenal gland cancer	0.000525	0.000557	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—adrenal gland cancer	0.000515	0.000546	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—EGFR—adrenal gland cancer	0.000515	0.000546	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000508	0.000539	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TERT—adrenal gland cancer	0.000481	0.000511	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.000477	0.000506	CbGpPWpGaD
Pranlukast—IL5—Immune System—EGFR—adrenal gland cancer	0.00047	0.000499	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—CTNNB1—adrenal gland cancer	0.000469	0.000498	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00046	0.000488	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.000426	0.000452	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—BAD—adrenal gland cancer	0.000419	0.000444	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CTNNB1—adrenal gland cancer	0.000414	0.000439	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PRKACA—adrenal gland cancer	0.0004	0.000425	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—POMC—adrenal gland cancer	0.000386	0.00041	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000384	0.000407	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—BRAF—adrenal gland cancer	0.000381	0.000404	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—EGFR—adrenal gland cancer	0.000371	0.000394	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000369	0.000392	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—BAD—adrenal gland cancer	0.000367	0.000389	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CTNNB1—adrenal gland cancer	0.000357	0.000379	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CDC42—adrenal gland cancer	0.00034	0.00036	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000336	0.000356	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—EGFR—adrenal gland cancer	0.000328	0.000348	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF2—adrenal gland cancer	0.000327	0.000347	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GNAS—adrenal gland cancer	0.000325	0.000344	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000317	0.000336	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—EGFR—adrenal gland cancer	0.000315	0.000334	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000314	0.000334	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EGFR—adrenal gland cancer	0.000304	0.000323	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—EGFR—adrenal gland cancer	0.000283	0.0003	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000281	0.000298	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000275	0.000292	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.000275	0.000292	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.000275	0.000292	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TERT—adrenal gland cancer	0.000272	0.000289	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—adrenal gland cancer	0.000255	0.000271	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CTNNB1—adrenal gland cancer	0.000241	0.000256	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—BAD—adrenal gland cancer	0.000237	0.000252	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—POMC—adrenal gland cancer	0.000219	0.000232	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EGFR—adrenal gland cancer	0.000218	0.000232	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—BRAF—adrenal gland cancer	0.000216	0.000229	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000205	0.000217	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—EGFR—adrenal gland cancer	0.000191	0.000203	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—adrenal gland cancer	0.000183	0.000194	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000183	0.000194	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000181	0.000192	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000181	0.000192	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000156	0.000165	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	0.000149	0.000159	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000146	0.000155	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000135	0.000143	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EGFR—adrenal gland cancer	0.000124	0.000131	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GNAS—adrenal gland cancer	0.000121	0.000129	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	0.000119	0.000126	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—adrenal gland cancer	0.000104	0.00011	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	9.85e-05	0.000105	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—POMC—adrenal gland cancer	8.15e-05	8.65e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GNAS—adrenal gland cancer	7.99e-05	8.48e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	7.84e-05	8.32e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	6.5e-05	6.9e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—POMC—adrenal gland cancer	5.38e-05	5.71e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	4.29e-05	4.55e-05	CbGpPWpGaD
